| EXL Stock | | | 0.05 0.01 31.43% |
President
Rob Hasselman is President Americas of Elixinol Wellness Limited
| Address | 680 George Street, Sydney, NSW, Australia, 2000 |
| Phone | 61 2 8280 7355 |
| Web | https://www.elixinolwellness.com |
Elixinol Wellness Management Efficiency
The company has return on total asset
(ROA) of
(0.2812) % which means that it has lost $0.2812 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.8721) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Wellness' management efficiency ratios could be used to measure how well Elixinol Wellness manages its routine affairs as well as how well it operates its assets and liabilities.
Total Current Liabilities is likely to drop to about 4.7
M in 2024.
Liabilities And Stockholders Equity is likely to drop to about 11.1
M in 2024
Similar Executives
Elixinol Wellness Limited (EXL) is traded on Australian Securities Exchange in Australia and employs 11 people. Elixinol Wellness is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Elixinol Wellness Leadership Team
Elected by the shareholders, the Elixinol Wellness' board of directors comprises two types of representatives: Elixinol Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixinol. The board's role is to monitor Elixinol Wellness' management team and ensure that shareholders' interests are well served. Elixinol Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixinol Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kim BradleyWare, Joint Sec | |
| Natalie Butler, Head Director | |
| Glen Zurcher, Account Department | |
| FCPA BEC, Interim Officer | |
| ACIS BA, Joint Secretary | |
| Teresa Cleary, G Sec | |
| Josephine Lorenz, Global Controller | |
| Rob Hasselman, President Americas | |
| Melanie Leydin, Company Secretary | |
| Beata Silber, Global Innovation | |
| Tai Phan, Joint Secretary | |
Elixinol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elixinol Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Elixinol Stock Analysis
When running Elixinol Wellness' price analysis, check to
measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to
predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.